A Brazilian Real-Life Experience of Multiple Myeloma Patients: Final Results from the Mmybrave Multi-Center Study

被引：1
|
作者：
Hungria, Vania T. M. [1 ]
Bittencourt, Rosane [2 ]
Martinez, Gracia [3 ]
Santos, Juliana De Andrade [4 ]
de Almeida, Denise Ramos [5 ]
De Piratininga Figueiredo, Vera Lucia [6 ]
Cordeiro De Farias, Danielle Leao [7 ]
Zanella, Karla Richter [8 ]
Muniz, Larissa Barchi [9 ]
Carvalho, Pedro [10 ]
Senra, Juliana [10 ]
Abreu, Rodrigo Martins [10 ]
Mattos, Ederson Roberto [11 ]
机构：
[1] Clin Sao Germano, Sao Paulo, Brazil
[2] Univ Fed Rio Grande do Sul, Hematol Div, Hosp Clin Porto Alegre HCPA, Porto Alegre, RS, Brazil
[3] Univ Sao Paulo, Fac Med, Hosp Clin, Sao Paulo, Brazil
[4] CEHON Ctr Hematol & Oncol, Salvador, BA, Brazil
[5] Hosp Sao Vicente de Paulo, Passo Fundo, RS, Brazil
[6] Hosp Servidor Publ Sao Paulo, Sao Paulo, Brazil
[7] Univ Fed Goias, Hosp Clin, Goiania, Go, Brazil
[8] CEPON Ctr Pesquisas Oncol, Florianopolis, SC, Brazil
[9] Casa Saude Santa Marcelina, Sao Paulo, Brazil
[10] Takeda Pharmaceut Brazil, Med Affairs, Sao Paulo, Brazil
[11] Fundacao Dr Amaral Carvalho, Ctr Ensino & Pesquisas, Jau, Brazil
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-166762
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：4352 / 4353
页数：2
相关论文
共 50 条
  • [21] Invasive fungal infections in patients with multiple myeloma: a multi-center study in the era of novel myeloma therapies
    Teh, Benjamin W.
    Teng, Jasmine C.
    Urbancic, Karin
    Grigg, Andrew
    Harrison, Simon J.
    Worth, Leon J.
    Slavin, Monica A.
    Thursky, Karin A.
    HAEMATOLOGICA, 2015, 100 (01) : E28 - E31
  • [22] Prognostic factors for regorafenib treatment in patients with refractory metastatic colorectal cancer: A real-life retrospective multi-center study
    Aydin, Sabin Goktas
    Kavak, Engin Eren
    Topcu, Atakan
    Bayramgil, Ayberk
    Akgul, Fahri
    Kahraman, Seda
    Aykan, Musa Baris
    Altintas, Yunus Emre
    Helvaci, Kaan
    Urun, Yuksel
    Bilici, Ahmet
    Seker, Mesut
    Sendur, Mehmet Ali Nahit
    Olmez, Omer Fatih
    Acikgoz, Ozgur
    Cicin, Irfan
    BIOMOLECULES AND BIOMEDICINE, 2023, 23 (06): : 1089 - 1095
  • [23] Thromboembolic events and thromboprophylaxis associated with immunomodulators in multiple myeloma patients: a real-life study
    V. Leclerc
    L. Karlin
    C. Herledan
    L. Marchal
    A. Baudouin
    A. Gouraud
    A. G. Caffin
    V. Larbre
    A. Lazareth
    E. Bachy
    G. Salles
    H. Ghesquières
    C. Rioufol
    F. Ranchon
    Journal of Cancer Research and Clinical Oncology, 2022, 148 : 975 - 984
  • [24] Thromboembolic events and thromboprophylaxis associated with immunomodulators in multiple myeloma patients: a real-life study
    Leclerc, V
    Karlin, L.
    Herledan, C.
    Marchal, L.
    Baudouin, A.
    Gouraud, A.
    Caffin, A. G.
    Larbre, V
    Lazareth, A.
    Bachy, E.
    Salles, G.
    Ghesquieres, H.
    Rioufol, C.
    Ranchon, F.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (04) : 975 - 984
  • [25] Retreatment of Patients with Anti CD38-Based Combinations in Multiple Myeloma in Real-Life: Results from the Emmy Cohort Study
    Hulin, Cyrille
    Perrot, Aurore
    Macro, Margaret
    Vekhoff, Anne
    Leleu, Xavier
    Karlin, Lionel
    Manier, Salomon
    Vincent, Laure
    El Yamani, Abderrazak
    Abarah, Wajed
    Kaphan, Regis
    Zarnitsky, Charles
    Re, Daniel
    Christophe, Laure
    Fitoussi, Olivier
    Texier, Nathalie
    Germain, Raphael
    Willaime, Marion
    Decaux, Olivier
    BLOOD, 2022, 140 : 7133 - 7135
  • [26] BENDAMUSTINE IN THE MANAGEMENT OF RELAPSED AND REFRACTORY MULTIPLE MYELOMA: A REGIONAL REAL-LIFE EXPERIENCE
    Cerchione, C.
    Catalano, L.
    Pareto, A. E.
    Basile, S.
    Marano, L.
    Peluso, I.
    Simeone, L.
    Vitagliano, O.
    Palmieri, S.
    Rocco, S.
    Ferrara, F.
    Pane, F.
    HAEMATOLOGICA, 2015, 100 : 743 - 744
  • [27] A Real-life study of Alemtuzumab in patients with Multiple Sclerosis: Kuwait's Experience
    Alroughani, Raed
    AlMojel, Malak
    Al-Hashel, Jasem
    Ahmed, Samar
    NEUROLOGY, 2023, 100 (17)
  • [28] REAL LIFE DATA FROM THE FIRST LINE TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA: EXPERIENCE OF A THIRD LEVEL CENTER
    Sanchez-Raga, J. M.
    Perez-Montana, A.
    Beltran, N.
    Ros, T.
    Boyeras, B.
    Martorell, C.
    Gutierrez, A.
    Sampol, A.
    HAEMATOLOGICA, 2019, 104 : 194 - 194
  • [29] FINAL RESULTS OF PHASE (PH) 1/2 STUDY OF CARFILZOMIB, POMALIDOMIDE, AND DEXAMETHASONE (KPD) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): A MULTI-CENTER MMRC STUDY
    Jakubowiak, A. J.
    Rosenbaum, C. A.
    Stephens, L.
    Kukreti, V.
    Cole, C.
    Zimmerman, T.
    Reece, D.
    Berdeja, J.
    Severson, E.
    Wolfe, B.
    Major, S.
    McDonnell, K.
    Nam, J.
    Turowski, A.
    Griffith, K.
    Zonder, J.
    HAEMATOLOGICA, 2017, 102 : 271 - 271
  • [30] A REAL LIFE SINGLE CENTER EXPERIENCE OF DARATUMUMAB, LENALDOMIDE AND DEXAMETHASONE COMBINATION IN MULTIPLE MYELOMA PATIENTS
    Attucci, I.
    Formica, G.
    Pilerci, S.
    Buzzichelli, A.
    Messeri, M.
    Vannucchi, A. M.
    Antonioli, E.
    HAEMATOLOGICA, 2021, 106 (10) : 165 - 165
12345